Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 409 to 411 of 411 entries
Sorted by: Best Match Show Resources per page
Harnessing of Doxylamine Succinate/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal.

Journal of pharmaceutical sciences

Salem HF, Ali AA, Hegazy AM, Sadek AA, Aboud HM.
PMID: 34808217
J Pharm Sci. 2021 Nov 20; doi: 10.1016/j.xphs.2021.11.007. Epub 2021 Nov 20.

The present work is concerned with tailoring and appraisal of a novel nano-cargo; bilosomes (BLS) dual laded with doxylamine succinate (DAS) and pyridoxine hydrochloride (PDH), the first treatment option against gestational nausea and vomiting, for intranasal delivery. This bifunctional...

Cite
Salem HF, Ali AA, Hegazy AM, et al. Harnessing of Doxylamine Succinate/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. J Pharm Sci. 2021;doi: 10.1016/j.xphs.2021.11.007.
Salem, H. F., Ali, A. A., Hegazy, A. M., Sadek, A. A., & Aboud, H. M. (2021). Harnessing of Doxylamine Succinate/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Journal of pharmaceutical sciences, . https://doi.org/10.1016/j.xphs.2021.11.007
Salem, Heba F, et al. "Harnessing of Doxylamine Succinate/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal." Journal of pharmaceutical sciences vol. (2021). doi: https://doi.org/10.1016/j.xphs.2021.11.007
Salem HF, Ali AA, Hegazy AM, Sadek AA, Aboud HM. Harnessing of Doxylamine Succinate/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. J Pharm Sci. 2021 Nov 20; doi: 10.1016/j.xphs.2021.11.007. Epub 2021 Nov 20. PMID: 34808217.
Copy Download .nbib Format: NLM
Use of pyridoxine hydrochloride in the interruption of lactation in female dogs with pseudopregnancy.

Animal reproduction

da Silva MC, Guedes PEB, Silva FL, Snoeck PPDN.
PMID: 33936292
Anim Reprod. 2021 Mar 31;18(1):e20200062. doi: 10.1590/1984-3143-AR2020-0062.

The aim of this research was to evaluate the use of pyridoxine hydrochloride and its associated side effects in the treatment of pseudopregnancy in female dogs. A total of 40 female dogs, with no defined breed, in non-gestational diestrus,...

Cite
da Silva MC, Guedes PEB, Silva FL, et al. Use of pyridoxine hydrochloride in the interruption of lactation in female dogs with pseudopregnancy. Anim Reprod. 2021;18(1):e20200062doi: 10.1590/1984-3143-AR2020-0062.
da Silva, M. C., Guedes, P. E. B., Silva, F. L., & Snoeck, P. P. D. N. (2021). Use of pyridoxine hydrochloride in the interruption of lactation in female dogs with pseudopregnancy. Animal reproduction, 18(1), e20200062. https://doi.org/10.1590/1984-3143-AR2020-0062
da Silva, Maíra Corona, et al. "Use of pyridoxine hydrochloride in the interruption of lactation in female dogs with pseudopregnancy." Animal reproduction vol. 18,1 (2021): e20200062. doi: https://doi.org/10.1590/1984-3143-AR2020-0062
da Silva MC, Guedes PEB, Silva FL, Snoeck PPDN. Use of pyridoxine hydrochloride in the interruption of lactation in female dogs with pseudopregnancy. Anim Reprod. 2021 Mar 31;18(1):e20200062. doi: 10.1590/1984-3143-AR2020-0062. PMID: 33936292; PMCID: PMC8078864.
Copy Download .nbib Format: NLM
West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature.

Frontiers in pediatrics

Gibaud M, Barth M, Lefranc J, Mention K, Villeneuve N, Schiff M, Maurey H, Barthez MA, Caubel I, Chouchane M, Doummar D, Kossorotoff M, Lamblin MD, Roubertie A, Nabbout R, Van Bogaert P.
PMID: 33748042
Front Pediatr. 2021 Mar 05;9:621200. doi: 10.3389/fped.2021.621200. eCollection 2021.

No abstract available.

Cite
Gibaud M, Barth M, Lefranc J, et al. West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature. Front Pediatr. 2021;9:621200doi: 10.3389/fped.2021.621200.
Gibaud, M., Barth, M., Lefranc, J., Mention, K., Villeneuve, N., Schiff, M., Maurey, H., Barthez, M. A., Caubel, I., Chouchane, M., Doummar, D., Kossorotoff, M., Lamblin, M. D., Roubertie, A., Nabbout, R., & Van Bogaert, P. (2021). West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature. Frontiers in pediatrics, 9621200. https://doi.org/10.3389/fped.2021.621200
Gibaud, Marc, et al. "West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature." Frontiers in pediatrics vol. 9 (2021): 621200. doi: https://doi.org/10.3389/fped.2021.621200
Gibaud M, Barth M, Lefranc J, Mention K, Villeneuve N, Schiff M, Maurey H, Barthez MA, Caubel I, Chouchane M, Doummar D, Kossorotoff M, Lamblin MD, Roubertie A, Nabbout R, Van Bogaert P. West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature. Front Pediatr. 2021 Mar 05;9:621200. doi: 10.3389/fped.2021.621200. eCollection 2021. PMID: 33748042; PMCID: PMC7973036.
Copy Download .nbib Format: NLM
Showing 409 to 411 of 411 entries